Tag: Canakinumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Canakinumab

EPS for Novartis AG (NVS) forecasted at $1.31

Added to Collection on: 2018-12-24 22:48:45

Tags for this article:

Business
Health
Biotechnology
New York Stock Exchange
Novartis
Seeking Alpha
Tilray
NVS
Canakinumab

Click the tags to see associated articles and topics

View Article Details
EPS for Novartis AG (NVS) Expected At $1.31 as of January, 23

Added to Collection on: 2018-12-24 22:37:30

Tags for this article:

Health
Biotechnology
Pharmaceutical industry
New York Stock Exchange
Novartis
Seeking Alpha
NVS
Canakinumab

Click the tags to see associated articles and topics

View Article Details
Novartis bets $1.6B on a biotech's anti-inflammatory drugs

Added to Collection on: 2019-04-01 00:07:30

Tags for this article:

Bristol-Myers Squibb
Novartis
Atlas Venture
Industries
Life Sciences
Medication
Canakinumab

Click the tags to see associated articles and topics

View Article Details
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how ...

Added to Collection on: 2021-01-12 12:56:15

Tags for this article:

Life Sciences
Pharmaceutical companies
Health sciences
Novartis
Canakinumab
Hydroxychloroquine
John Tsai

Click the tags to see associated articles and topics

View Article Details
Canakinumab Plus Chemotherapy Show No OS Improvement in Advanced or Metastatic NSCLC

Added to Collection on: 2021-03-09 21:33:45

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Lung cancer
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Canakinumab
Pembrolizumab
Non-small-cell lung carcinoma
Adjuvant therapy
Novartis

Click the tags to see associated articles and topics

View Article Details
Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants ...

Added to Collection on: 2021-06-28 15:56:15

Tags for this article:

Companies
Life Sciences
Industry economics)
Novartis
Genentech
Canakinumab
Chiron Corporation
Secukinumab

Click the tags to see associated articles and topics

View Article Details
Book a Demo